Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Corrigendum to "Cost-effectiveness of first-line osimertinib informed by electronic medical records via text-mining: a real-world Italian case study of EGFR-mutated advanced NSCLC patients": [ESMO Real World Data and Digital Oncology Volume 10, December 2025, 100198].
ESMO real world data and digital oncology·2026
Data analytics for real-world data integration in TKI-treated NSCLC patients using electronic health records.
ESMO real world data and digital oncology·2026
Savolitinib plus osimertinib in epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer with MET overexpression and/or amplification following disease progression on osimertinib: primary results from the phase II SAVANNAH study.
Annals of oncology : official journal of the European Society for Medical Oncology·2025
Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial (NCT03921671).
Annals of oncology : official journal of the European Society for Medical Oncology·2024
Cardiac tamponade: an unusual, fatal complication of infective endocarditis.
Giornale italiano di cardiologia·2000
Treatment of a native right coronary artery with the PercuSurge Guardwire protection system during PTCA and stenting.
Giornale italiano di cardiologia·2000
Relief of an early pulmonary pathway obstruction with stenting after modified Fontan operation in an adult.
Giornale italiano di cardiologia·2000
[Clinical characteristics, familial distribution and preliminary genetic data in 9 different families with "Brugada's syndrome"].
Giornale italiano di cardiologia·2000
[Clinical course of pre- and post-natal isolated congenital atrioventricular block diagnosed in utero].
Giornale italiano di cardiologia·2000
Associations of Cholesin and GPR146 with atherosclerotic plaque stability: integrated bioinformatics and functional analyses.
Frontiers in cardiovascular medicine·2026
Caveolin-1 levels associated with coronary artery disease in Chinese participants: a retrospective cohort study.
Frontiers in cardiovascular medicine·2026
PCSK9 inhibitors for lipid-lowering treatment in patients with atherosclerotic cardiovascular disease: a health technology assessment.
Frontiers in cardiovascular medicine·2026